Delphi Technologies PLC (NYSE:DLPH)

Rowley Law PLLC is investigating potential securities law violations by Delphi Technologies PLC (NYSE: DLPH) and its board of directors concerning the proposed acquisition of the company by BorgWarner, Inc. (NYSE: BWA). Stockholders will receive 0.4534 shares of BorgWarner common stock for each share of Delphi Technologies stock that they hold. The transaction is valued […]

Delphi Technologies PLC (NYSE:DLPH)2020-04-30T21:57:48+00:00

Franklin Financial Network, Inc. (NYSE: FSB)

Rowley Law PLLC is investigating potential securities law violations by Franklin Financial Network, Inc. (NYSE: FSB) and its board of directors concerning the proposed acquisition of the company by FB Financial Corporation (NYSE: FBK). Stockholders will receive 0.9650 shares of FB Financial common stock and $2.00 in cash for each share of Franklin stock that […]

Franklin Financial Network, Inc. (NYSE: FSB)2020-04-30T21:57:53+00:00

Hexcel Corporation (NYSE:HXL)

Rowley Law PLLC is investigating potential securities law violations by Hexcel Corporation (NYSE:HXL) and its board of directors concerning the proposed acquisition of the company by Woodward, Inc. (NASDAQ: WWD). Stockholders will receive 0.625 shares of Woodward common stock for each share of Hexcel stock that they hold. The transaction is valued at $6.4 billion […]

Hexcel Corporation (NYSE:HXL)2020-04-30T21:58:01+00:00

Primo Water Corporation (NASDAQ: PRMW)

Rowley Law PLLC is investigating potential securities law violations by Primo Water Corporation (NASDAQ: PRMW) and its board of directors concerning the proposed acquisition of the company by Cott Corporation (NYSE: COT, TSX: BCB). Primo Water Corp. stockholders will receive $5.04 in cash and 0.6549 common shares of Cott for each Primo common stock that […]

Primo Water Corporation (NASDAQ: PRMW)2020-04-30T21:58:07+00:00

Dermira, Inc. (NASDAQ: DERM)

Rowley Law PLLC is investigating potential securities law violations by Dermira, Inc. (NASDAQ: DERM) and its board of directors concerning the proposed acquisition of the company by Eli Lilly and Company (NYSE: LLY). Stockholders will receive $18.75 per share of Dermira, Inc. common stock that they hold. The transaction is valued at approximately $1.1 billion […]

Dermira, Inc. (NASDAQ: DERM)2020-03-12T15:26:41+00:00
Go to Top